Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹31,813.1
₹67,601 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,596.6
₹32,435 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹568.6
₹8,949 Cr
Pharmaceuticals & Drugs
₹910.6
₹8,253 Cr
Pharmaceuticals & Drugs
₹468.2
₹4,273 Cr
Pharmaceuticals & Drugs
₹309.7
₹3,465 Cr
Pharmaceuticals & Drugs
₹111.9
₹2,873 Cr
Pharmaceuticals & Drugs
₹151.1
₹735 Cr
Pharmaceuticals & Drugs
₹828.2
₹473 Cr
Pharmaceuticals & Drugs
₹55.0
₹156 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,596.6
₹4,648 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹568.6
₹4,118 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹468.2
₹2,387 Cr
Pharmaceuticals & Drugs
₹910.6
₹2,115 Cr
Pharmaceuticals & Drugs
₹309.7
₹637 Cr
Pharmaceuticals & Drugs
₹111.9
₹222 Cr
Pharmaceuticals & Drugs
₹151.1
₹73 Cr
Pharmaceuticals & Drugs
₹31,813.1
₹6,409 Cr
Pharmaceuticals & Drugs
₹828.2
₹346 Cr
Pharmaceuticals & Drugs
₹55.0
₹474 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,596.6
₹920 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹568.6
₹344 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹910.6
₹272 Cr
Pharmaceuticals & Drugs
₹468.2
₹168 Cr
Pharmaceuticals & Drugs
₹111.9
₹145 Cr
Pharmaceuticals & Drugs
₹309.7
₹134 Cr
Pharmaceuticals & Drugs
₹151.1
₹3 Cr
Pharmaceuticals & Drugs
₹31,813.1
₹1,414 Cr
Pharmaceuticals & Drugs
₹828.2
₹17 Cr
Pharmaceuticals & Drugs
₹55.0
₹4 Cr

You may also like the below Video Courses